25(OH)D modifies the relationship between depressive symptoms and chronic kidney disease in diabetic patients
International Urology and Nephrology · 2025
DOI: 10.1007/s11255-025-04898-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Urology and Nephrology, 2025. Verfasst von Ying Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Nanjing University of Chinese Medicine, 157 Hanzhong Road, Nanjing, 210029, People's Republic of China. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Vitamin D, Depression, Diabetes Mellitus. Die Arbeit nennt 58 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: 25-hydroxyvitamin D [25(OH)D] is closely related to depressive symptoms and chronic kidney disease (CKD), especially in diabetic patients. This study aimed to determine whether elevated 25(OH)D could modify the association of depressive symptoms and CKD in diabetic patients. METHODS: We conducted a cross-sectional study, included diabetic patients from the National Health and Nutrition Examination Survey from 2007-2008 to 2017-2018. The Patient Health Questionnaire 9 (PHQ-9) indicates depressive symptoms. 25(OH)D was stratified according to the median (56.1 nmol/L). Weighted logistic regression models were used to quantify the association between depressive symptoms and CKD. The model was adjusted for age, sex, race, education, smoking and alcohol status, and hypertension. As an exploratory analysis, we used the likelihood ratio test to calculate the interaction. Johnson-Neyman analysis was used to determine the 25(OH)D concentration at which significant and non-significant associations between depressive symptom and CKD occurred in linear models. RESULTS: This study included a total of 5196 diabetic patients. After adjusting for all confounding factors, PHQ-9 score ≥ 10 was independent risk factors for CKD (OR = 1.31, 95%CI 1.01-1.64). When 25(OH)D ≤ 56.1 nmol/L, PHQ-9 score ≥ 10 was associated with CKD (OR = 1.65, 95%CI 1.22-2.23), but when 25(OH)D > 56.1 nmol/L, PHQ-9 score ≥ 10 was not associated with CKD (OR = 1.00, 95%CI 0.69-1.45). The interaction showed that elevated 25(OH)D modifies the association between depressive symptoms and CKD (P for interaction = 0.039). The modification concentration of 25(OH)D was 58.7 nmol/L. CONCLUSION: Elevated 25(OH)D modifies the relationship between depressive symptoms and CKD in diabetic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Nanjing University of Chinese Medicine, 157 Hanzhong Road, Nanjing, 210029, People's Republic of China.
- Department of Neurology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, People's Republic of China. ljq557ljq99@163.com.
- The First Clinical Medical College, Nanjing University of Chinese Medicine, 157 Hanzhong Road, Nanjing, 210029, People's Republic of China. weiyunfei_1212@163.com.
- The First Clinical Medical College, Nanjing University of Chinese Medicine, 157 Hanzhong Road, Nanjing, 210029, People's Republic of China. lzg1073@sina.com.
Zitieren
APA
Yang, Y., Wang, Q., Ge, X., He, Y., Chen, X., Huang, X., Wu, Y., Liao, J., Wei, Y., & Guo, L. (2025). 25(OH)D modifies the relationship between depressive symptoms and chronic kidney disease in diabetic patients. International Urology and Nephrology. https://doi.org/10.1007/s11255-025-04898-0
Vancouver
Yang Y, Wang Q, Ge X, He Y, Chen X, Huang X, et al. 25(OH)D modifies the relationship between depressive symptoms and chronic kidney disease in diabetic patients. International Urology and Nephrology. 2025. doi:10.1007/s11255-025-04898-0
BibTeX
@article{Yang2025,
author = {Yang, Ying and Wang, Qian and Ge, Xiyu and He, Yuhua and Chen, Xiangyi and Huang, Xin and Wu, You and Liao, Junqi and Wei, Yunfei and Guo, Lizhong},
title = {25(OH)D modifies the relationship between depressive symptoms and chronic kidney disease in diabetic patients},
journal = {International Urology and Nephrology},
year = {2025},
doi = {10.1007/s11255-025-04898-0}
}
EUVIMED